We are live on
!
Find out more
CAPTRUST Financial Advisors Portfolio holdings
AUM
$57.3B
1-Year Est. Return
18.32%
This Fund
S&P 500
This Quarter
Est. Return
+8.78%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$44.8B
AUM Growth
+$4.96B
(+12%)
Cap. Flow
+$1.85B
Cap. Flow
% of AUM
4.12%
Top 10 Holdings %
Top 10 Hldgs %
25.91%
Holding
2,610
New
259
Increased
1,374
Reduced
774
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$394M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$231M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$228M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$116M |
| 5 |
UGI
UGI
|
+$88.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$173M |
| 2 |
Capital Group International Focus Equity ETF
CGXU
|
+$141M |
| 3 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$128M |
| 4 |
Vanguard Small-Cap Value ETF
VBR
|
+$114M |
| 5 |
Pinnacle West Capital
PNW
|
+$52.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.1% |
| 2 | Financials | 7.7% |
| 3 | Healthcare | 4.61% |
| 4 | Industrials | 4.59% |
| 5 | Consumer Discretionary | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHY
2451
Credit Suisse High Yield Credit Fund
DHY
$238M
| $36K | ﹤0.01% |
16,922
+371
| +2% | +$757 |
|
2452
ImmunityBio
IBRX
$7.44B
| $35.3K | ﹤0.01% |
13,386
+2,645
| +25% | +$7.11K |
|
2453
Blend Labs
BLND
$409M
| $35.1K | ﹤0.01% |
+10,645
| New | +$36.1K |
|
2454
Krispy Kreme
DNUT
$543M
| $34.2K | ﹤0.01% |
+11,763
| New | +$41.1K |
|
2455
Lexicon Pharmaceuticals
LXRX
$1.02B
| $33.6K | ﹤0.01% |
35,582
+2,398
| +7% | +$1.55K |
|
2456
Wipro
WIT
$18.5B
| $32.1K | ﹤0.01% |
10,619
-2,450
| -19% | -$7.12K |
|
2457
Ironwood Pharmaceuticals
IRWD
$611M
| $31.9K | ﹤0.01% |
+44,447
| New | +$34.9K |
|
2458
Nuvation Bio
NUVB
$2.24B
| $31.6K | ﹤0.01% |
+16,199
| New | +$33.7K |
|
|
IRD
2459
Opus Genetics
IRD
$254M
| $30.1K | ﹤0.01% |
32,000
+4,000
| +14% | +$3.71K |
|
2460
Editas Medicine
EDIT
$399M
| $26K | ﹤0.01% |
+11,802
| New | +$19.3K |
|
2461
Hyliion Holdings
HYLN
$663M
| $25.5K | ﹤0.01% |
19,326
-226
| -1% | -$329 |
|
2462
GoPro
GPRO
$116M
| $25K | ﹤0.01% |
33,041
+15,618
| +90% | +$10.1K |
|
2463
Armata Pharmaceuticals
ARMP
$171M
| $25K | ﹤0.01% |
13,140
| – | – |
|
2464
C4 Therapeutics
CCCC
$376M
| $24.4K | ﹤0.01% |
17,039
+637
| +4% | +$926 |
|
2465
8x8 Inc
EGHT
$247M
| $22.7K | ﹤0.01% |
11,591
+1,270
| +12% | +$2.24K |
|
2466
Fate Therapeutics
FATE
$281M
| $22K | ﹤0.01% |
19,604
+3,175
| +19% | +$3.69K |
|
|
ADVM
2467
DELISTED
Adverum Biotechnologies
ADVM
| $21.5K | ﹤0.01% |
10,000
-624
| -6% | -$1.75K |
|
2468
Geron
GERN
$911M
| $20.3K | ﹤0.01% |
14,391
-1,014
| -7% | -$1.44K |
|
|
ADAP
2469
DELISTED
Adaptimmune Therapeutics
ADAP
| $19K | ﹤0.01% |
79,083
-1,526
| -2% | -$407 |
|
2470
Leslie's
LESL
$11.6M
| $17.5K | ﹤0.01% |
2,081
+1,524
| +274% | +$20.1K |
|
2471
Tiziana Life Sciences
TLSA
$114M
| $17.4K | ﹤0.01% |
11,000
-6,000
| -35% | -$8.02K |
|
2472
Rafael Holdings
RFL
$111M
| $17.4K | ﹤0.01% |
+10,036
| New | +$16.4K |
|
2473
SmartRent
SMRT
$183M
| $16.7K | ﹤0.01% |
+16,823
| New | +$15K |
|
2474
RenovoRx
RNXT
$39M
| $16.2K | ﹤0.01% |
+12,307
| New | +$14K |
|
2475
Plug Power
PLUG
$2.92B
| $15.9K | ﹤0.01% |
+10,677
| New | +$10.7K |
|
Similar funds
NAMI
CAPTRUST Financial Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, CAPTRUST Financial Advisors held 2,610 positions worth $44.8B, up 12% from $39.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
CAPTRUST Financial Advisors deployed $1.85B of net new capital in Q2 2025, opening 259 new positions and adding to 1,374 existing holdings. Its largest new stake was Maplebear: 394,286 shares worth $17.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $173M trimmed.
- CAPTRUST Financial Advisors's largest Q2 2025 buy was Maplebear: 394,286 shares worth $17.8M.
- CAPTRUST Financial Advisors added most to iShares Core MSCI Total International Stock ETF in Q2 2025, an estimated $394M increase.
- CAPTRUST Financial Advisors's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $173M.
- CAPTRUST Financial Advisors fully exited Innovator US Equity Buffer ETF July in Q2 2025, selling an estimated $10.8M.
- CAPTRUST Financial Advisors's ten largest holdings make up 26% of its $44.8B portfolio in Q2 2025.
- CAPTRUST Financial Advisors opened 259 new positions and closed 104 in Q2 2025.
- CAPTRUST Financial Advisors's portfolio value rose 12% quarter-over-quarter to $44.8B.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.